12:00 AM
 | 
Mar 30, 2009
 |  BC Week In Review  |  Company News  |  Deals

Human Genome Sciences, Eisai deal

Eisai's Morphotek Inc. subsidiary and Human Genome partnered to research mAbs against HGSI's cancer and immunology targets....

Read the full 75 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >